A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures-Reference-Cited by-同舟云学术

A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures

Published:2013-09-20 Issue:11 Volume:54 Page:1968-1976
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Abou-Khalil Bassel¹,Wheless James²,Rogin Joanne³,Wolter Kevin D.⁴,Pixton Glenn C.⁵,Shukla Rajesh B.⁶,Sherman Nancy A.⁴,Sommerville Kenneth⁵⁷,Goli Veeraindar⁵⁷,Roland Carl L.⁵

Affiliation:

1. Vanderbilt University Medical Center; Nashville Tennessee U.S.A.

2. University of Tennessee Health Science Center and LeBonheur Children's Hospital; Memphis Tennessee U.S.A.

3. Midwest Center for Seizure Disorders; Minneapolis Clinic of Neurology; Golden Valley Minnesota U.S.A.

4. Pfizer, Inc.; New York New York U.S.A.

5. Pfizer, Inc.; Cary North Carolina U.S.A.

6. Meridian Medical Technologies, Inc.; Columbia Maryland U.S.A.

7. Duke University Medical Center; Cary North Carolina U.S.A.

Funder

Pfizer Inc.

Helen Varley

Pfizer Inc./King Pharmaceuticals